{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif

Instructions : Please tick the right option & in case of few questions you can tick more than one option
  1. In your clinical practice, what percentage of patients are managed using intervention techniques? *

  2. In your patients with ACS who are to undergo intervention, what is the LDL-C goal (mg/dL) that you will target to have before the procedure? *

  3. What % of patient achieved more than 50% reduction in LDL-C post PCI after statin treatment? *

  4. To prepare a patient for intervention, what are the molecules that are used as a loading dose? (Multiple options can be selected) *

  5. In what percentage of your patients do you use high intensity statins as a loading dose to PCI patients? *

  6. In what profile of patients do you need to use a high intensity statin in the loading dose regimen for a PCI? (Multiple options can be selected) *

  7. Which of the following is your preferred statin and its loading dose prior to PCI. Please state the reason for the preference? *

    		8.

  8. In your practice, which of the following patient profile do you prefer to initiate high intensity statin? *

  9. From your clinical experience, how would you rate safety and efficacy of below statin. Please rate from 1-5, with 1 being very low and 5 being very high ? *
    10. SAFETY EFFICACY

  10. When do you usually start high intensity statin in ACS patients? *

  11. According to you, what are the clinical benefits of using a high intensity statin pretreatment undergoing PCI? *

  12. Post PCI, which agents are prescribed to your patients for improved clinical outcomes ? (Multiple options can be selected) *

  13. In post PCI patients, for how long do you recommend taking high-intensity statins ? *

  14. Post PCI completion, what is the LDL-C goal (mg/dL) that you would prefer to target in your patients ? *

  15. In the event that your patients do not achieve their LDL-C goals even after high-intensity statins, which will be your preferred agent to be added to attain LDL-C goal? *

    16. Part B : Understanding the usage of statin & combinations in the management of high-risk patients
  16. In your opinion, what are the clinical benefits of using a high intensity statin pretreatment undergoing PCI? *

  17. Usually in your patients with ACS what is the duration of DAPT therapy that you usually prefer? *

  18. Post DAPT therapy, how long do you prefer anti-platelet monotherapy? *

  19. In your patients with high bleeding risk what duration of initial DAPT do you usually prefer? *

  20. Post DAPT therapy how long do you prefer anti-platelet monotherapy? *

  21. Which among the following choices do you recommend for anti-platelet monotherapy? *

  22. In your opinion, which are the limiting factors in the management of high CV risk patients? *

  23. For secondary prevention patient who is on statin & LDL C levels are >70 mg/dL, what treatment strategy would you prefer? *
    24. Option 1 Tick Option 2 Tick
    Start with 20mg Rosuvastatin/ 20 mg Atorvastatin Escalate to 40mg Rosuvastatin or 40 mg Atorvastatin

    1. Add ezetimibe with moderate intensity Statin
    2. Add Bempedoic acid

    After 20mg Atorvastatin/20 mg Rosuvastatin Escalate to 80mg Atorvastatin or 40 mg Rosuvastatin

    1. Add ezetimibe with moderate intensity Statin
    2. Add Bempedoic acid

  24. In your secondary prevention patients for how long do you recommend your patients to take high intensity statin? *

  25. In your high risk secondary prevention patients with LDL-C above target even after high-intensity statin therapy what percentage of patients would you be keen to initiate? *
    26. Molecule % of patients
    Moderate intensity statin + Ezetimibe
    High intensity statin + Bempedoic acid
    PCSK9 inhibitors